Original paper

Persistence of apremilast in moderate‐to‐severe psoriasis: a real‐world analysis of 14 147 apremilast‐ and methotrexate‐naive patients in the French National Health Insurance database

Volume: 182, Issue: 3, Pages: 690 - 697
Published: Jul 22, 2019
Abstract
Real‐world data on the persistence of apremilast vs. methotrexate are inconclusive. To assess and compare the long‐term persistence of apremilast and methotrexate in a large cohort of patients with psoriasis. All adult patients with psoriasis registered in the French national health insurance database (‘Système National des Données de Santé’) between 2009 and 2017 were eligible for inclusion. The study population comprised apremilast‐ and...
Paper Details
Title
Persistence of apremilast in moderate‐to‐severe psoriasis: a real‐world analysis of 14 147 apremilast‐ and methotrexate‐naive patients in the French National Health Insurance database
Published Date
Jul 22, 2019
Volume
182
Issue
3
Pages
690 - 697
Citation AnalysisPro
  • Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
  • Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.